Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Milena Bond"'
Autor:
Sofia Ramiro, Louise Falzon, Christian Dejaco, Cristina Ponte, Wolfgang A Schmidt, Sarah Louise Mackie, Philipp Bosch, Milena Bond
Publikováno v:
RMD Open, Vol 9, Iss 3 (2023)
Objectives To update the evidence on imaging for diagnosis, monitoring and outcome prediction in large vessel vasculitis (LVV) to inform the 2023 update of the European Alliance of Associations for Rheumatology recommendations on imaging in LVV.Metho
Externí odkaz:
https://doaj.org/article/94ccf5b56cae43cd8cec9651fb92bfc0
Autor:
Sofia Ramiro, Christian Dejaco, Catalina Sanchez-Alvarez, Melanie Anderson, Zahi Touma, Carol A Langford, Dario Camellino, Milena Bond, Medha Soowamber
Publikováno v:
RMD Open, Vol 9, Iss 2 (2023)
Objectives To identify criteria and descriptors used to measure response to treatment and change in disease activity in giant cell arteritis (GCA).Methods A systematic literature review (SLR) to retrieve randomised controlled trials (RCTs) and longit
Externí odkaz:
https://doaj.org/article/950b1b463bc84a9dbb31bde905ec0d19
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 14 (2022)
Although great improvements have been achieved in the fields of diagnosing and treating patients with giant-cell arteritis (GCA) in the last decades, several questions remain unanswered. The progressive increase in the number of older people, togethe
Externí odkaz:
https://doaj.org/article/67cb09a651d845b08604cf81145e344a
Autor:
Alvise Berti, Milena Bond, Alessandro Volpe, Mara Felicetti, Roberto Bortolotti, Giuseppe Paolazzi
Publikováno v:
Beyond Rheumatology, Vol 2 (2020)
Primary systemic vasculitides are rare diseases affecting blood vessel walls. The type and patterns of distribution of the organs affected usually reflect the size of the vessels predominantly involved, and the patterns of clinical manifestations are
Externí odkaz:
https://doaj.org/article/35e513c4b6824e1a82065395b644a573
At the Heart of Eosinophilic Granulomatosis with Polyangiitis: into Cardiac and Vascular Involvement
Autor:
Milena Bond, Filippo Fagni, Michele Moretti, Federica Bello, Allyson Egan, Augusto Vaglio, Giacomo Emmi, Christian Dejaco
Publikováno v:
Current rheumatology reportsReferences Papers of particular interest, published recently, have been highlighted as: • Of importance. 24(11)
To provide an overview of existing literature on pathogenetic and clinical aspects of cardiac and vascular involvement in eosinophilic granulomatosis with polyangiitis (EGPA).In EGPA, cardiac and vascular involvement are more common than previously t
Publikováno v:
Rheumatology (Oxford, England).
Autor:
Alessandro Volpe, Mara Felicetti, Alvise Berti, Giuseppe Paolazzi, Milena Bond, Roberto Bortolotti
Publikováno v:
Beyond Rheumatology. 2:3-13
Primary systemic vasculitides are rare diseases affecting blood vessel walls. The type and patterns of distribution of the organs affected usually reflect the size of the vessels predominantly involved, and the patterns of clinical manifestations are
Autor:
Christian Dejaco, Andreas Kerschbaumer, Daniel Aletaha, Milena Bond, Elvis Hysa, Dario Camellino, Lisa Ehlers, Andy Abril, Simone Appenzeller, Maria C Cid, Bhaskar Dasgupta, Christina Duftner, Peter C Grayson, Bernhard Hellmich, Alojzija Hočevar, Tanaz A Kermani, Eric L Matteson, Susan P Mollan, Lorna Neill, Cristina Ponte, Carlo Salvarani, Sebastian Eduardo Sattui, Wolfgang A Schmidt, Philip Seo, Josef S Smolen, Jens Thiel, Carlos Enrique Toro-Gutiérrez, Madeline Whitlock, Frank Buttgereit
Publikováno v:
Annals of the Rheumatic Diseases. :ard-2022
ObjectivesTo develop treat-to-target (T2T) recommendations in giant cell arteritis (GCA) and polymyalgia rheumatica (PMR).MethodsA systematic literature review was conducted to retrieve data on treatment targets and outcomes in GCA/PMR as well as to
Autor:
Christian Dejaco, Sofia Ramiro, Zahi Touma, Milena Bond, Medha Soowamber, Catalina Sanchez-Alvarez, Carol A Langford
Publikováno v:
Annals of the Rheumatic Diseases. :ard-2022
Glucocorticoids (GCs) are the gold standard for treatment of giant cell arteritis (GCA); however, there is a need for studies on GC-sparing agents, given that up to 85% of patients receiving GC only develop adverse events. Previous randomised control
Publikováno v:
Therapeutic advances in musculoskeletal disease. 14
Although great improvements have been achieved in the fields of diagnosing and treating patients with giant-cell arteritis (GCA) in the last decades, several questions remain unanswered. The progressive increase in the number of older people, togethe